BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 19, 2011
 |  BC Week In Review  |  Company News  |  Deals

Affymax, Takeda deal

Affymax and Takeda said the pharma has decided not to commercialize anemia product peginesatide in Japan. The partners will explore other options for commercializing the product in Japan, including licensing to a third party. Takeda, which said...

Read the full 164 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >